MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. income statement MHUAF
In fiscal 2025, which ended Dec 31, 2025, MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. reported revenue of $61.8 million, down 36.2% from the year before. Net income was $6.8 million, a profit margin of 11.0%. Operating income came to $8.3 million, an operating margin of 13.4%. Diluted earnings per share were $18.04. Across the 5 fiscal years shown, revenue shrank from $104.0 million in fiscal 2021 to $61.8 million in fiscal 2025, about 12.2% a year.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
|---|---|---|---|---|---|
| Revenue |
62
-36.2%
|
97
-0.2%
|
97
-6.0%
|
103
-0.7%
|
104
|
| Cost of revenue |
43
-33.0%
|
64
-0.5%
|
64
-2.1%
|
65
+1.6%
|
64
|
| Gross profit |
19
-42.5%
|
33
+0.3%
|
33
-12.9%
|
38
-4.3%
|
40
|
| Research and development |
2
-31.0%
|
3
+25.5%
|
3
-7.1%
|
3
+8.7%
|
3
|
| Selling, general and administrative |
7
-48.4%
|
14
+4.2%
|
14
-29.3%
|
20
+81.0%
|
11
|
| Operating income |
8
-42.1%
|
14
-2.5%
|
15
+35.9%
|
11
-58.9%
|
26
|
| Interest income |
1
+24.1%
|
1
+16.1%
|
1
|
—
|
—
|
| Interest expense |
0
|
—
|
—
|
—
|
—
|
| Foreign currency gain (loss) |
0
-90.6%
|
0
+347.8%
|
-0
-156.1%
|
0
+56.8%
|
0
|
| Other non-operating income (expense) |
0
-34.3%
|
0
+209.6%
|
-0
|
—
|
—
|
| Pretax income |
9
-31.0%
|
14
-9.5%
|
15
+38.2%
|
11
-58.5%
|
26
|
| Income tax |
3
-5.9%
|
3
-19.3%
|
3
-26.6%
|
5
-10.7%
|
5
|
| Net income |
7
-37.5%
|
11
-6.7%
|
12
+86.2%
|
6
-70.2%
|
21
|
| Basic EPS |
18.04
-54.5%
|
39.62
-18.4%
|
48.56
+17885.2%
|
0.27
-74.3%
|
1.05
|
| Diluted EPS |
18.04
|
—
|
48.56
+17885.2%
|
0.27
|
—
|
| Weighted average shares, basic |
0
+37.4%
|
0
+14.3%
|
0
-99.0%
|
23
+17.1%
|
20
|
| Weighted average shares, diluted |
0
+37.4%
|
0
+14.3%
|
0
-99.0%
|
23
|
—
|
| Other measures | |||||
| Depreciation and amortization |
1
-1.8%
|
1
+33.2%
|
0
-24.6%
|
1
-9.1%
|
1
|
| EBITDA |
9
-40.6%
|
15
-1.5%
|
15
+33.0%
|
11
-57.8%
|
27
|
| Interest coverage |
34.30x
|
—
|
—
|
—
|
—
|
| Margins | |||||
| Gross margin |
31.01%
|
34.36%
|
34.19%
|
36.86%
|
38.26%
|
| Operating margin |
13.41%
|
14.77%
|
15.11%
|
10.45%
|
25.24%
|
| Pretax margin |
15.22%
|
14.06%
|
15.50%
|
10.54%
|
25.21%
|
| Profit margin |
10.98%
|
11.19%
|
11.97%
|
6.04%
|
20.14%
|
| EBITDA margin |
14.27%
|
15.33%
|
15.53%
|
10.98%
|
25.81%
|
| Effective tax rate |
27.90%
|
20.47%
|
22.98%
|
43.28%
|
20.13%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MHUAF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Yangzhou, China
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1835615
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.